Laval University MBA Pharmaceutical Management Fees, Requirement, Application, Deadline 2026.

Laval University Master of Business Administration (MBA) Pharmaceutical Management is a 45-credit professional master’s degree in Quebec City, delivered full-time on campus over about 2 years. Applicants need a bachelor’s degree or equivalent. The minimum average is 3.22 on 4.33, approximately 75% to 80% or CGPA (cumulative grade point average) 7.5 to 8.0 on 10 for Indian applicants. Summer 2027 tuition is unpublished; 2026-27 tuition was C$42,008.85 (INR 28.99 Lakhs), as a prior-cycle reference.

The programme links business administration with strategic pharmaceutical management across industries, pharmacies, health-care establishments and government organizations. It suits applicants who want to manage medicines, markets or health-sector operations, while the French academic environment and the absence of a pharmacist-licensure pathway are important fit considerations.

• Students can select an international profile with one or two semesters at a partner university outside Canada.
• Certain courses are available in English, although French remains central to the programme’s academic environment.
• Distance and hybrid delivery options can help part-time students adjust their study pace around existing work.

Also Check: Laval MBA admission

Laval University MBA Pharmaceutical Fees and Living Costs 2027

Summer 2027 international tuition is unpublished after checking the programme, application and official fee surfaces. Verify the target fee on the official fee page before making an education-loan or study-permit budget.

The table below records the official 2026-27 course-based international charges as prior-cycle references. The 45-credit tuition is calculated from the published per-course rate rather than presented as a target-cycle quote.

Source: Université Laval’s 2026-27 tuition and budgeting schedule used as a prior-cycle reference.

All INR conversions in the article use a conversion rate of CAD 1 = INR 69 as of 16 June 2026. Rates fluctuate daily, verify before applying.

• The calculated 45-credit figure uses 15 courses multiplied by C$2,800.59 (INR 1.93 Lakhs), so the university’s 2027-28 billing schedule must replace this illustration.
• The C$475 (INR 32,775) application fee is separate from tuition and should be included in the initial cash requirement.
• Insurance is a separate annual charge, so a two-year plan should not treat the published 24-credit tuition figure as an all-in amount.

Cost of Living in Quebec City for Pharmaceutical Management Students

The official Quebec City student budget is C$1,382 (INR 95,358) per month, or C$16,584 (INR 11.44 Lakhs) annually. Laval presents this as a combined student estimate, so it should not be rewritten as a rent, food or transport breakdown.

Residence prices and the Canadian study-permit maintenance requirement answer different questions from the university estimate. Keep the combined living figure as a planning baseline, then check your housing choice and immigration proof separately.

Source: Université Laval international student cost-of-living estimate for Quebec City.

A prior-cycle planning illustration uses calculated 45-credit tuition of C$42,008.85 (INR 28.99 Lakhs). It adds two years of living costs at C$33,168 (INR 22.89 Lakhs). Insurance totals C$1,800 (INR 1.24 Lakhs) for two years, plus the C$475 (INR 32,775) application fee.

The resulting calculated amount is C$77,451.85 (INR 53.44 Lakhs) for the two-year illustration, excluding travel, books and any 2027-28 fee change. It is not a target-cycle quote and should be refreshed when the university publishes the new schedule.

Check Out: Canada cost of studying guide

ROI reality: Summer 2027 tuition is unpublished. Use the C$77,451.85 (INR 53.44 Lakhs) figure only as prior-cycle planning context and confirm the new fee before accepting a loan.

Laval University MBA Pharmaceutical Management Admission 2027

Admission requires a bachelor’s degree or equivalent, a qualifying academic record and French evidence for applicants whose primary and secondary education was not in French. The programme is designed for applicants who can connect prior study or work to pharmaceutical management, although the university makes the final decision from the complete file and available resources.

For Summer 2027, the published academic threshold is 3.22 on 4.33, with a case-by-case route for averages from 2.80 to 3.21. The approximate Indian readings below are planning guidance, not a replacement for Laval’s institutional equivalency decision.

The 2.80 to 3.21 range can keep an application viable, but it increases the importance of the presentation letter, mathematics preparation and relevant pharmaceutical or health-sector direction. No programme-level GMAT (Graduate Management Admission Test) or GRE (Graduate Record Examinations) condition is listed in the checked requirements, so neither test replaces the published academic or language evidence.

French and English Language Requirements

French is the principal language checkpoint because Laval states that teaching, assignments and examinations are in French, even though selected courses may be offered in English. TCF means Test de connaissance du français, and the required result must be recent and submitted with the application.

English is not an admission condition, but the university warns that students need strong English reading comprehension because many academic resources are in English. Indian applicants should therefore treat French as the admissions gate and English reading as a completion skill.

• Book TCF-TP preparation early enough to attach the result before the 01 December 2026 Summer 2027 deadline.
• Use the French-language degree exemption only when the awarding institution can document French as its teaching language.
• Map calculus, linear algebra and vector geometry against your Indian transcript before relying on conditional admission.

Tip for Indian students: The 3.22 average is only one filter, so submit French evidence and document mathematics before the 01 December 2026 Summer 2027 deadline.

Laval University MBA Pharmaceutical Management Application 2027

The Summer 2027 international application is open, while Fall 2027 and Winter 2028 are announced options with later deadlines. Because the programme lists all three admission semesters, an applicant can choose timing around French testing, transcript preparation and study-permit planning.

The official schedule publishes application opening dates and international deadlines but does not publish decision dates or an interview stage for this programme. The date-only deadlines below therefore need to be checked in the application portal, whose cutoff timezone controls submission.

The official application schedule identifies applicants outside Canada as the relevant deadline category and warns that late files can be postponed because of Quebec Acceptance Certificate and study-permit processing.

Summer 2027 is the earliest applicant-accessible intake and should be the priority when French, transcript and funding evidence are ready. Fall 2027 creates a later route with more preparation time, while Winter 2028 offers the longest runway but postpones entry into the pharmaceutical management curriculum.

Application File and Submission Strategy

Start the online file with the programme documents rather than treating the application as a general MBA submission. The strongest file will connect a prior pharmaceutical, health-care, science or business background to a specific management problem in medicines, markets, health services or public administration.

Decision dates are not published on the checked programme and application pages, so applicants should not make travel or resignation commitments from an assumed response date. Submit a complete file before the relevant international deadline and retain portal confirmation.

• Attach the approximately two-page presentation letter and use it to explain the move from your previous preparation into pharmaceutical management.
• Submit the TCF-TP result or accepted French alternative with the file when your prior primary and secondary education was not in French.
• Map differential calculus, linear algebra and vector geometry against your transcript before the university assesses any conditional mathematics requirement.
• Keep the international secondary-school examination transcript ready because it is listed alongside the curriculum vitae and presentation letter.

Application tip: Treat 01 December 2026 as the operational Summer 2027 cutoff, complete French testing first and make your pharmaceutical-management rationale central to the presentation letter.

Laval University MBA Pharmaceutical Management Scholarships 2027

FSA ULaval lists admission, excellence, mobility, progress and graduation support for master’s students, but target Summer 2027 award dates are not published. The values below are current published award descriptions rather than guaranteed reductions from the unpublished 2027-28 tuition.

The official scholarship programme separates entry funding from awards earned after enrolment. Indian applicants should therefore prepare the full prior-cycle funding plan and treat any award as an upside until the relevant competition confirms eligibility.

All five values are current published funding information, while the target-cycle application route and date must be confirmed in the relevant notice. No award should be converted into a target-cycle net tuition because the university has not published the Summer 2027 fee or a remission mechanism for this MBA.

• Keep the C$77,451.85 (INR 53.44 Lakhs) prior-cycle planning illustration available because an admission award is competitive and the target tuition is still unpublished.
• Use the mobility award only when your study plan includes the approved international profile rather than treating it as general tuition support.
• Protect second-session cash flow because progress support is an enrolment-stage award rather than an upfront admission discount.
• Match the presentation letter and academic record to the leadership criteria before relying on the C$5,000 (INR 3.45 Lakhs) maximum.

Scholarship reality: Entry awards can reduce the initial gap but are competitive and cycle-sensitive, while progress and graduation awards require enrolment, so arrange initial funding without counting them.

Laval University MBA Pharmaceutical Management Salary 2027

No course-specific salary, offer rate or placement report was published for the Laval MBA Pharmaceutical Management in the checked programme and career materials. That limitation matters because a market wage cannot be presented as a typical graduate outcome or used as a guaranteed payback figure.

Université Laval’s pharmaceutical-sciences career material identifies pathways in biopharmaceutical companies, pharmaceutical manufacturers, clinical research, health economics, public administration and sales. The external Quebec figures below are occupational benchmarks from the 2023-2024 Labour Force Survey, so they show possible market context rather than Laval graduate performance.

Source: Government of Canada Job Bank wage tables and Université Laval pharmaceutical-sciences career-market material, with the occupational scope retained.

The benchmarks are useful for testing career direction, not for predicting an MBA salary. A sales role may value negotiation and market knowledge, clinical research requires evidence coordination and regulated documentation, while manufacturing management usually depends on operational experience in addition to the degree.

ROI for Indian Applicants

The financial case is a planning exercise rather than a forecast because Summer 2027 tuition and course-specific employment outcomes are unpublished. Use the following verified inputs to decide what must be confirmed before committing funds:

• The prior-cycle two-year planning illustration is C$77,451.85 (INR 53.44 Lakhs), so request a fresh 2027-28 fee schedule before finalising a loan amount.
• No course placement rate or graduate salary is published, so compare any written offer with the full updated cost instead of using the Quebec median as a payback promise.
• The Quebec pharmaceutical sales median is C$33.65 per hour (INR 2,322 per hour), so applicants targeting commercial roles should build negotiation, market-access or product skills alongside French.
• Use the C$38.46 (INR 2,654) clinical-research median to target regulated-project experience before borrowing.
• Compare the PGWP work window tied to programme length with updated cost before choosing Canada.

Take-home pay varies with Quebec and federal tax, the Canada Pension Plan and Employment Insurance. Use the Canada Revenue Agency tax information before converting a gross hourly benchmark into a repayment estimate.

ROI reality: The financial case depends on a defined medicines, clinical-research, manufacturing or sales pathway. Confirm the target-cycle fee before borrowing.

Canada Visa for Laval University MBA Pharmaceutical Students 2027

Indian students need a Quebec Acceptance Certificate (CAQ) and a federal study permit for this Quebec-based MBA. The CAQ supports the study-permit file, while the permit authorizes study in Canada, so budget and document for both steps after receiving the university decision.

• The study-permit fee is C$150 (INR 10,350), and the cached maintenance figure is C$20,000 (INR 13.80 Lakhs).
• The cached PGWP (Post-Graduation Work Permit) rule matches permit duration to programme length, allows open work without employer sponsorship and records a maximum of four years.
• The cached route uses C$62,000 (INR 42.78 Lakhs), 12 months of experience and about six months of Express Entry processing.
• Use CRS 450 and about 12 months only as cached planning references, then confirm Quebec rules.

Read More: Canada student visa requirements

Visa reality: The MBA’s two-year structure supports a work window linked to programme length. Secure the CAQ, show separate funds and confirm Quebec’s settlement rules before choosing a post-study plan.

Laval University MBA Pharmaceutical Management Ranking 2027

No ranking dedicated to the Laval MBA Pharmaceutical Management was identified. The latest relevant subject context is the Times Higher Education 2026 Business and Economics band, which covers the university’s broader business disciplines rather than this pharmaceutical-management programme.

• The subject band can provide broad institutional context, but it does not establish Pharmaceutical Management employment, salary or admission competitiveness.
• The programme’s industry, health-care and government focus makes curriculum fit, French readiness and target-sector access more useful decision measures than a broad subject band.

Honest take: Treat the 2026 Business and Economics band as university-level context only, then judge the MBA by its pharmaceutical-management proposition, language demands and verified funding plan.